Key result
Severe acute radiation esophagitis predicts a ~17-fold higher risk of symptomatic radiation pneumonitis.
Why the study?
Radiation-induced pneumonitis is a serious complication in thoracic radiation patients, and the predictive value of acute radiation-induced esophagitis for symptomatic radiation pneumonitis is unclear.
Does acute radiation-induced esophagitis predict symptomatic radiation pneumonitis in thoracic cancer patients receiving radiotherapy?
Cohort (n=123)
No
Does acute radiation-induced esophagitis predict symptomatic radiation pneumonitis in thoracic cancer patients receiving radiotherapy?
Odds Ratio: 16.763 (95% CI 3.638–77.23)
Absolute Event Rate: 44.2% vs 6.5%
p-value: p=<0.001
Acute radiation-induced esophagitis is a strong early predictor of symptomatic radiation pneumonitis in thoracic cancer patients receiving radiotherapy.
May support closer pneumonitis surveillance after severe esophagitis; leaves open causality and need for prospective validation.
BACKGROUND: Radiation-induced pneumonitis (RP) is a non-negligible and sometimes life-threatening complication among patients with thoracic radiation. We initially aimed to ascertain the predictive value of acute radiation-induced esophagitis (SARE, grade ≥ 2) to symptomatic RP (SRP, grade ≥ 2) among thoracic cancer patients receiving radiotherapy. Based on that, we established a novel nomogram model to provide individualized risk assessment for SRP. METHODS: Thoracic cancer patients who were treated with thoracic radiation from Jan 2018 to Jan 2019 in Shandong Cancer Hospital and Institute were enrolled prospectively. All patients were followed up during and after radiotherapy (RT) to observe the development of esophagitis as well as pneumonitis. Variables were analyzed by univariate and multivariate analysis using the logistic regression model, and a nomogram model was established to predict SRP by "R" version 3.6.0. RESULTS: A total of 123 patients were enrolled (64 esophageal cancer, 57 lung cancer and 2 mediastinal cancer) in this study prospectively. RP grades of 0, 1, 2, 3, 4 and 5 occurred in 29, 57, 31, 0, 3 and 3 patients, respectively. SRP appeared in 37 patients (30.1%). In univariate analysis, SARE was shown to be a significant predictive factor for SRP (P < 0.001), with the sensitivity 91.9% and the negative predictive value 93.5%. The incidence of SRP in different grades of ARE were as follows: Grade 0-1: 6.5%; Grade 2: 36.9%; Grade 3: 80.0%; Grade 4: 100%. Besides that, the dosimetric factors considering total lung mean dose, total lung V5, V20, ipsilateral lung mean dose, ipsilateral lung V5, and mean esophagus dose were correlated with SRP (all P < 0.05) by univariate analysis. The incidence of SRP was significantly higher in patients whose symptoms of RP appeared early. SARE, mean esophagus dose and ipsilateral mean lung dose were still significant in multivariate analysis, and they were included to build a predictive nomogram model for SRP. CONCLUSIONS: As an early index that can reflect the tissue's radiosensitivity visually, SARE can be used as a predictor for SRP in patients receiving thoracic radiation. And the nomogram containing SARE may be fully applied in future's clinical work.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2021) conducted a cohort in Thoracic cancer receiving radiotherapy (n=123). Severe acute radiation-induced esophagitis (SARE, grade ≥ 2) vs. Grade 0-1 acute radiation-induced esophagitis was evaluated on Symptomatic radiation-induced pneumonitis (SRP, grade ≥ 2) (OR 16.763, 95% CI 3.638-77.230, p=<0.001). Severe acute radiation-induced esophagitis (grade ≥ 2) independently predicted the development of symptomatic radiation-induced pneumonitis in patients receiving thoracic radiotherapy (OR 16.763).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: